Intelligent Bio Solutions (INBS) Invested Capital (2019 - 2024)
Intelligent Bio Solutions has reported Invested Capital over the past 6 years, most recently at $11.0 million for Q1 2024.
- Quarterly results put Invested Capital at $11.0 million for Q1 2024, up 71.26% from a year ago — trailing twelve months through Mar 2024 was $11.0 million (up 71.26% YoY), and the annual figure for FY2023 was $3.7 million, down 60.7%.
- Invested Capital for Q1 2024 was $11.0 million at Intelligent Bio Solutions, up from $3.2 million in the prior quarter.
- Over the last five years, Invested Capital for INBS hit a ceiling of $19.2 million in Q4 2020 and a floor of -$5.9 million in Q1 2020.
- Median Invested Capital over the past 5 years was $8.7 million (2022), compared with a mean of $7.4 million.
- Biggest five-year swings in Invested Capital: skyrocketed 18615.25% in 2021 and later plummeted 80.1% in 2023.
- Intelligent Bio Solutions' Invested Capital stood at $19.2 million in 2020, then plummeted by 47.67% to $10.1 million in 2021, then increased by 7.23% to $10.8 million in 2022, then crashed by 70.74% to $3.2 million in 2023, then soared by 248.67% to $11.0 million in 2024.
- The last three reported values for Invested Capital were $11.0 million (Q1 2024), $3.2 million (Q4 2023), and $1.2 million (Q3 2023) per Business Quant data.